Price to Book Value (P/BV)
since 2005
Calculation
Merck & Co. Inc., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Merck & Co., Inc. stockholders’ equity1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 7.83 | = | 79.94 | ÷ | 10.21 | 10.21 | = | 25,907 | ÷ | 2,536,268,760 | |
| Dec 31, 2018 | 7.79 | = | 80.62 | ÷ | 10.34 | 10.34 | = | 26,701 | ÷ | 2,581,220,308 | |
| Dec 31, 2017 | 4.30 | = | 54.72 | ÷ | 12.74 | 12.74 | = | 34,336 | ÷ | 2,696,190,502 | |
| Dec 31, 2016 | 4.51 | = | 65.87 | ÷ | 14.60 | 14.60 | = | 40,088 | ÷ | 2,745,571,067 | |
| Dec 31, 2015 | 3.15 | = | 50.64 | ÷ | 16.10 | 16.10 | = | 44,676 | ÷ | 2,775,258,591 | |
| Dec 31, 2014 | 3.42 | = | 58.54 | ÷ | 17.14 | 17.14 | = | 48,647 | ÷ | 2,838,192,933 | |
| Dec 31, 2013 | 3.35 | = | 56.66 | ÷ | 16.92 | 16.92 | = | 49,765 | ÷ | 2,940,622,461 | |
| Dec 31, 2012 | 2.44 | = | 42.73 | ÷ | 17.54 | 17.54 | = | 53,020 | ÷ | 3,022,367,538 | |
| Dec 31, 2011 | 2.14 | = | 38.38 | ÷ | 17.91 | 17.91 | = | 54,517 | ÷ | 3,044,008,396 | |
| Dec 31, 2010 | 1.85 | = | 32.57 | ÷ | 17.64 | 17.64 | = | 54,376 | ÷ | 3,083,080,697 | |
| Dec 31, 2009 | 1.97 | = | 37.27 | ÷ | 18.96 | 18.96 | = | 59,058 | ÷ | 3,115,317,260 | |
| Dec 31, 2008 | 2.72 | = | 24.20 | ÷ | 8.90 | 8.90 | = | 18,758 | ÷ | 2,107,712,364 | |
| Dec 31, 2007 | 5.38 | = | 45.20 | ÷ | 8.40 | 8.40 | = | 18,185 | ÷ | 2,165,289,746 | |
| Dec 31, 2006 | 5.45 | = | 44.15 | ÷ | 8.11 | 8.11 | = | 17,560 | ÷ | 2,166,483,163 | |
| Dec 31, 2005 | 4.30 | = | 35.20 | ÷ | 8.19 | 8.19 | = | 17,917 | ÷ | 2,187,042,320 |
Based on: 10-K (filing date: 2020-02-26), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-27), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-28), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-28), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-13).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Merck & Co. Inc.’s Annual Report.
Comparison to Competitors
Merck & Co. Inc., P/BV, long-term trends, comparison to competitors
| Merck & Co. Inc. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 7.83 | 4.96 | — | 13.84 | 4.40 | 2.80 | 51.67 | 3.93 | 9.43 | 6.61 | 3.00 | 3.79 | 10.23 | 25.42 |
| Dec 31, 2018 | 7.79 | 4.38 | — | 9.41 | 5.03 | 5.89 | 12.87 | 3.89 | 11.43 | 6.08 | 3.80 | 5.07 | 10.68 | 18.74 |
| Dec 31, 2017 | 4.30 | 3.40 | 36.95 | 5.02 | 5.80 | 8.88 | 7.33 | 5.15 | 11.79 | 5.79 | 2.94 | 5.66 | 20.14 | 21.52 |
| Dec 31, 2016 | 4.51 | 3.76 | 21.24 | 4.14 | 4.70 | 5.66 | 6.33 | 4.88 | 10.95 | 4.72 | 3.40 | 8.58 | 18.42 | 17.46 |
| Dec 31, 2015 | 3.15 | 2.68 | 22.17 | 3.94 | 6.31 | 7.04 | 5.51 | 6.59 | 12.50 | 4.07 | 2.84 | 10.53 | 22.38 | 19.72 |
| Dec 31, 2014 | 3.42 | 3.32 | 56.09 | 4.59 | 8.49 | 6.72 | 5.14 | 10.08 | 19.53 | 4.01 | 2.95 | 16.22 | 25.60 | 17.61 |
| Dec 31, 2013 | 3.35 | 2.38 | 18.05 | 4.30 | 8.25 | 5.92 | 3.69 | 11.36 | 14.25 | 3.50 | 2.69 | 16.74 | 14.77 | 15.56 |
| Dec 31, 2012 | 2.44 | 2.06 | 18.06 | 3.57 | 5.34 | 4.40 | 4.15 | 7.01 | 4.58 | 3.29 | 2.42 | 12.91 | 10.08 | 4.15 |
| Dec 31, 2011 | 2.14 | 3.61 | — | 2.83 | 4.53 | 3.50 | 3.35 | 5.08 | 5.83 | 3.13 | 1.95 | 19.19 | 10.05 | — |
| Dec 31, 2010 | 1.85 | 3.24 | — | 2.04 | 2.94 | 2.76 | 3.21 | 5.29 | 7.40 | 2.88 | 1.75 | 6.42 | 16.16 | — |
| Dec 31, 2009 | 1.97 | 3.69 | — | 2.46 | 2.34 | 2.88 | 4.17 | 6.74 | 5.06 | 3.45 | 1.57 | 5.49 | 7.45 | — |
| Dec 31, 2008 | 2.72 | 4.78 | — | 2.48 | 2.69 | 3.29 | 5.01 | 9.83 | 4.59 | 3.56 | 1.44 | 2.94 | 21.09 | — |
| Dec 31, 2007 | 5.38 | 4.83 | — | 2.77 | 3.38 | 4.22 | 4.16 | 11.76 | 10.05 | 4.17 | 2.32 | 3.24 | 8.92 | — |
| Dec 31, 2006 | 5.45 | 5.88 | — | 3.96 | 2.25 | 5.50 | 5.43 | 18.07 | 8.16 | 4.78 | 2.49 | 5.77 | 7.52 | — |
| Dec 31, 2005 | 4.30 | 4.69 | — | 4.26 | 2.27 | 4.00 | 5.85 | 9.18 | 14.56 | 4.66 | 2.94 | 8.16 | 18.12 | — |
Based on: 10-K (filing date: 2020-02-26), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-27), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-28), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-28), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-13).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Merck & Co. Inc., P/BV, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Merck & Co. Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2019 | 7.83 | 6.28 |
| Dec 31, 2018 | 7.79 | 6.55 |
| Dec 31, 2017 | 4.30 | 5.53 |
| Dec 31, 2016 | 4.51 | 4.92 |
| Dec 31, 2015 | 3.15 | 4.48 |
| Dec 31, 2014 | 3.42 | 4.94 |
| Dec 31, 2013 | 3.35 | 4.22 |
| Dec 31, 2012 | 2.44 | 3.31 |
| Dec 31, 2011 | 2.14 | 2.78 |
| Dec 31, 2010 | 1.85 | 2.40 |
| Dec 31, 2009 | 1.97 | 2.56 |
| Dec 31, 2008 | 2.72 | 2.99 |
| Dec 31, 2007 | 5.38 | 3.73 |
| Dec 31, 2006 | 5.45 | 4.11 |
| Dec 31, 2005 | 4.30 | 4.02 |
Based on: 10-K (filing date: 2020-02-26), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-27), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-28), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-28), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-13).
Comparison to Industry (Health Care)
Merck & Co. Inc., P/BV, long-term trends, comparison to industry (health care)
| Merck & Co. Inc. | Health Care | |
|---|---|---|
| Dec 31, 2019 | 7.83 | 5.41 |
| Dec 31, 2018 | 7.79 | 5.41 |
| Dec 31, 2017 | 4.30 | 4.86 |
| Dec 31, 2016 | 4.51 | 4.33 |
| Dec 31, 2015 | 3.15 | 3.90 |
| Dec 31, 2014 | 3.42 | 4.47 |
| Dec 31, 2013 | 3.35 | 3.82 |
| Dec 31, 2012 | 2.44 | 3.05 |
| Dec 31, 2011 | 2.14 | 2.62 |
| Dec 31, 2010 | 1.85 | 2.36 |
| Dec 31, 2009 | 1.97 | 2.44 |
| Dec 31, 2008 | 2.72 | 2.72 |
| Dec 31, 2007 | 5.38 | 3.53 |
| Dec 31, 2006 | 5.45 | 3.86 |
| Dec 31, 2005 | 4.30 | 4.17 |
Based on: 10-K (filing date: 2020-02-26), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-27), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-28), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-28), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-13).